Malladi drugs and pharmaceuticals to set up global hub in Malaysia
9 Oct 2008, 1608 Hrs

Add comment          Mail          Print          Write to Editor

Kuala Lumpur, Oct 9 (ANI/Business Wire India): Malladi Drugs and Pharmaceuticals Ltd plans to make substantial investment over the next 3-5 years to set up its global "one-stop shop" in Malaysia.

Malladi Drugs handed over a business plan to Malaysian Biotechnology Corp (Biotech), on the first day of the BioMalaysia 2008 conference and exhibition in the presence of the Malaysian Prime Minister Datuk Seri Abdullah Ahmad Badawi.

According to the plan, the firm aims to expand into other areas of service offering as a contract research organisation in Malaysia including oncology and steroids, and beta-lactums.

Prashant Malladi, Managing Director, Malladi Drugs and Pharmaceuticals Ltd said, "We have been studying this model for some time and are convinced that Malladi is positioned perfectly to deliver this."

BioTech's chief executive officer, Datuk Iskandar Mizal Mahmood, said the firm has yet to pick a site, but would be encouraged to locate at one of the economic corridors in the country, in line with Prime Minister Datuk Seri Abdullah Ahmad Badawi's call for those areas to be driven by biotechnology.

"The investment entails the development of the entire value chain within the contract manufacturing facility starting from the API formulation," he said.

Biotech, one of the main organisers of BioMalaysia, is the lead agency for the biotechnology industry in Malaysia.

Malladi Drugs and Pharmaceutical Ltd is an API manufacturer based out of Chennai, India. The Company has a strong footing and experience in Research and Development and manufacturing of API with a deep rooted experience of more than 50 years. The company intends to expand its service base in the value chain providing the concept of "One-Stop-Shop".

As part of the expansion plan, Malladi intends to establish a Malaysian entity. This entity will serve as a foot-print for the company in the next few stages of the value chain like Formulation R andD, Manufacturing, and Formulation Clinicals. The company also intends to extend its expertise in Oncology and Steroids and in Beta-lactums. (ANI)

Related Latest

Goa all set to host IFFI from Monday A-listers set to watch Ledger's 'The Imaginarium of Doctor Parnassus' AirAsia set to become most connected non-local airline in India India urges West to give up beef to slow down global warming Firecracker hub Sivakasi wants another 'a' in its name Top global jazz musicians to play in capital Delhi Archdiocese offers to set up schools in Delhi, Haryana NGO to set up hospital for camels in Jaipur AirAsia plans to spread in India, hub in Bangkok Ireland's failure to qualify for World Cup set to trigger diplomatic row with France

Related Latest

As far as Kashmir issue is concerned, India will not redraw borders: Singh Pakistan has not done enough on the Mumbai terror attacks: Manmohan Singh No apprehension about US viewing India differently: Manmohan Singh Winters leave Ladakh out of bound, make stocking of food material a must Eco-friendly vehicles rally held in Delhi People worship Highway Goddess for safe journey in Chennai Lucknow Zoo authorities treating tiger for cancer Hussey ready to cop criticism, but will let bat do the talking PAC supports idea of making Pak Army's financial records public Pak heading towards 'demographic disaster', warn experts

• As far as Kashmir issue is concerned, India will not redraw borders: Singh
• Pakistan has not done enough on the Mumbai terror attacks: Manmohan Singh
• No apprehension about US viewing India differently: Manmohan Singh
• Lucknow Zoo authorities treating tiger for cancer
• Winters leave Ladakh out of bound, make stocking of food material a must

• भारतीय क्रिकेट की मजबूत दीवार
• कंगारूओं के आगे ढेर, चीतों से कैसे मुकाबला करेंगें शेर
• Reducing greenhouse gases may not be enough to slow global warming
• बीकानेर महापौर चुनावः एक विश्लेषण
• Deepawali: The Festival Of Lights